{"result":[{"lastName":"Myers","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty, Acad Council,Medicine - Nephrology"}],"primaryAppointment":"Emeritus Faculty, Acad Council,Medicine - Nephrology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4332&type=small&showNoImage","displayName":"Bryan Myers","firstName":"Bryan","href":"http://med.stanford.edu/profiles/cancer/researcher/Bryan_Myers","researchInterest":"A novel approach is used to evaluate glomerular disease in humans, and its progression.  A combination of physiologic techniques, a morphometric analysis of glomeruli obtained by biopsy, and mathematical modeling of glomerular ultrafiltration is used to quantify the extent of glomerular injury in humans for the first time."},{"lastName":"Altmann","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Neurology & Neurological Sciences"}],"primaryAppointment":"Postdoctoral Research fellow, Neurology & Neurological Sciences","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=33212&type=small&showNoImage","displayName":"Andre Altmann","firstName":"Andre","href":"http://med.stanford.edu/profiles/postdocs/researcher/Andre_Altmann","researchInterest":""},{"lastName":"Sabatti","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor,Health Research & Policy - Biostatistics"},{"appointment":"Member,Bio-X"},{"appointment":"Associate Professor (By courtesy),Natural Sciences Cluster - Statistics"}],"primaryAppointment":"Associate Professor,Health Research & Policy - Biostatistics","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=14357&type=small&showNoImage","displayName":"Chiara Sabatti","firstName":"Chiara","href":"http://med.stanford.edu/profiles/cancer/researcher/Chiara_Sabatti","researchInterest":"Statistical models and reasoning are key to our understanding of the genetic basis of human traits. Modern high-throughput technology presents us with new opportunities and challenges. We develop statistical approaches for high dimensional data in the attempt of improving our understanding of the molecular basis of health related traits."},{"lastName":"Cohen","clinicalFocus":[{"focus":"Hematology, Pediatric"},{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor,Pediatrics"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor,Pediatrics","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=3801&type=small&showNoImage","displayName":"Harvey Cohen","firstName":"Harvey","href":"http://med.stanford.edu/profiles/cancer/researcher/Harvey_Cohen","researchInterest":"My research interests extend from hypothesis-driven studies in biochemistry and cell biology to discovery-driven interests in proteomics and systems biology to clinical treatment of acute lymphoblastic leukemia of children, and pediatric palliative care."},{"lastName":"Ioannidis","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - Stanford Prevention Research Center"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Health Research & Policy - Epidemiology"},{"appointment":"Professor (By courtesy),Natural Sciences Cluster - Statistics"}],"primaryAppointment":"Professor,Medicine - Stanford Prevention Research Center","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=18745&type=small&showNoImage","displayName":"John Ioannidis","firstName":"John","href":"http://med.stanford.edu/profiles/cancer/researcher/John_Ioannidis","researchInterest":"Evidence-based medicine\r\nClinical and molecular epidemiology\r\nHuman genome epidemiology\r\nResearch design\r\nReporting of research\r\nEmpirical evaluation of bias in research\r\nRandomized trials\r\nStatistical methods and modeling\r\nMeta-analysis and large-scale evidence\r\nPrognosis, predictive and personalized medicine and health\r\nSociology of science"},{"lastName":"Jeffrey","clinicalFocus":[{"focus":"General Surgery"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4147&type=small&showNoImage","displayName":"Stefanie S. Jeffrey, MD","firstName":"Stefanie","href":"http://med.stanford.edu/profiles/cancer/researcher/Stefanie_Jeffrey","researchInterest":"Dr. Jeffrey was team leader of the multidisciplinary team from the School of Medicine, School of Engineering, and Genome Technology Center that invented the MagSweeper automated technology to isolate live circulating tumor cells (CTCs) from cancer patient blood for single cell analysis. Her lab characterizes CTCs in different cancers, investigating CTC profiles and mutations as potential companion diagnostics to define individual patient response to newer biologically-based cancer therapies."},{"lastName":"Palaniappan","clinicalFocus":[{"focus":"Internal Medicine"}],"appointments":[],"imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6447&type=small&showNoImage","displayName":"Latha Palaniappan, MD, MS","firstName":"Latha","href":"http://stanfordhospital.org/profiles/cancer/physician/Latha_Palaniappan","researchInterest":"Latha Palaniappan is currently an Associate Investigator at the Palo Alto Medical Foundation Research Institute, an Adjunct Clinical Assistant Professor at Stanford University and Clinical Assistant Professor at the University of California San Francisco. Dr. Palaniappan has completed over 20 studies spanning 10 years in the areas of ethnicity, obesity, and diabetes risk. She currently leads the Pan Asian Cohort Study (www.pamf.org/pacs), to investigate diabetes in Asian Americans"},{"lastName":"Lazzeroni","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor (Research),Psychiatry & Behavioral Science"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Associate Professor (Research),Psychiatry & Behavioral Science","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4220&type=small&showNoImage","displayName":"Laura C. Lazzeroni, Ph.D.","firstName":"Laura","href":"http://med.stanford.edu/profiles/cancer/researcher/Laura_Lazzeroni","researchInterest":""},{"lastName":"Meyer","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - Nephrology"}],"primaryAppointment":"Professor,Medicine - Nephrology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4497&type=small&showNoImage","displayName":"Timothy Meyer","firstName":"Timothy","href":"http://med.stanford.edu/profiles/cancer/researcher/Timothy_Meyer","researchInterest":"Inadequate removal of uremic solutes contributes to widespread illness in the more than 350,000 Americans maintained on hemodialysis.   But we know remarkably little about these solutes.  Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal  could be increased.  We should be able to improve treatment if we knew more about what we are trying to remove."},{"lastName":"Grant","clinicalFocus":[{"focus":"Infectious Disease"}],"appointments":[{"appointment":"Instructor,Medicine - Infectious Diseases"}],"primaryAppointment":"Instructor,Medicine - Infectious Diseases","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=9694&type=small&showNoImage","displayName":"Philip Grant","firstName":"Philip","href":"http://med.stanford.edu/profiles/cancer/researcher/Philip_Grant","researchInterest":""},{"lastName":"John","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7425&type=small&showNoImage","displayName":"Esther M. John","firstName":"Esther","href":"http://med.stanford.edu/profiles/cancer/researcher/Esther_John","researchInterest":"Etiology of breast, prostate and ovarian cancer; cancer in Hispanics and African-Americans; migration and acculturation in Hispanics; modifiable lifestyle factors (vitamin D, physical activity, body size, heterocyclic amines, occupational exposures); genetic susceptibility; gene-environment interactions"},{"lastName":"Whitin","clinicalFocus":[],"appointments":[{"appointment":"Senior Research Scientist,Pediatrics - Hematology & Oncology"}],"primaryAppointment":"Senior Research Scientist,Pediatrics - Hematology & Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=9730&type=small&showNoImage","displayName":"John Whitin","firstName":"John","href":"http://cancer.stanford.edu/profiles/John_Whitin","researchInterest":""},{"lastName":"Holodniy","clinicalFocus":[{"focus":"Infectious Disease"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Infectious Diseases"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Infectious Diseases","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4021&type=small&showNoImage","displayName":"Mark Holodniy","firstName":"Mark","href":"http://med.stanford.edu/profiles/cancer/researcher/Mark_Holodniy","researchInterest":"My research program is currently focused in three areas: 1) translational research (HCV/HIV viral evolution and antiviral resistance prevalence and development), 2) HIV/HCV clinical trials (diagnostic assay/medical device, antiretrovirals, ARVs and immunomodulators), and 3) health services research focusing on cost effectiveness of HIV antibody and ARV resistance testing and ARV utilization and clincal outcome."},{"lastName":"Clarke","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7430&type=small&showNoImage","displayName":"Christina Clarke","firstName":"Christina","href":"http://med.stanford.edu/profiles/cancer/researcher/Christina_Clarke","researchInterest":"Dr. Clarke\u0092s research efforts are centered in five areas: 1) the epidemiology of breast cancer, 2) the epidemiology of lymphoid malignancies 3) immunologic and viral causes of malignancy, and 4) cancer surveillance and creative uses of and ways to visually display cancer surveillance data (e.g, SEER, cancer registry data) and more recently, 5) internet-based, patient-centric methods for recruitment and data collection in epidemiologic studies."},{"lastName":"Mohan","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Medicine"}],"primaryAppointment":"Postdoctoral Research fellow, Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=23128&type=small&showNoImage","displayName":"Shalini Mohan","firstName":"Shalini","href":"http://med.stanford.edu/profiles/postdocs/researcher/Shalini_Mohan","researchInterest":""},{"lastName":"Whittemore","clinicalFocus":[],"appointments":[{"appointment":"Professor,Health Research & Policy - Epidemiology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Health Research & Policy - Epidemiology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4482&type=small&showNoImage","displayName":"Alice S Whittemore","firstName":"Alice","href":"http://med.stanford.edu/profiles/cancer/researcher/Alice_Whittemore","researchInterest":"Cancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers."},{"lastName":"Rosenberg","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor,Biology (School of Humanities and Sciences)"}],"primaryAppointment":"Associate Professor,Biology (School of Humanities and Sciences)","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=23986&type=small&showNoImage","displayName":"Noah Rosenberg","firstName":"Noah","href":"http://med.stanford.edu/profiles/cancer/researcher/Noah_Rosenberg","researchInterest":"Research in the lab addresses problems in evolutionary biology and human \r\ngenetics through a combination of mathematical modeling, computer \r\nsimulations, development of statistical methods, and inference from \r\npopulation-genetic data.  Our current work covers topics such as human \r\ngenetic variation, inference of human evolutionary history, the role of \r\npopulation genetics in the search for disease-susceptibility genes, the \r\nrelationship of gene trees and species trees, and mathematical pr"},{"lastName":"Glaser","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7426&type=small&showNoImage","displayName":"Sally Glaser","firstName":"Sally","href":"http://med.stanford.edu/profiles/cancer/researcher/Sally_Glaser","researchInterest":"Dr. Glaser\u0092s interests in cancer epidemiology focus primarily on Hodgkin lymphoma, breast cancer, and Surveillance Research (the use of population-based cancer and other data to monitor cancer occurrence and related population patterns).  In these areas, her work addresses cancer etiology and outcomes related to several risk factors, including EBV and HIV."},{"lastName":"Tang","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Medical fellow, Medicine"}],"primaryAppointment":"Postdoctoral Medical fellow, Medicine","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=17624&type=small&showNoImage","displayName":"Michele Tang","firstName":"Michele","href":"http://med.stanford.edu/profiles/postdocs/researcher/Michele_Tang","researchInterest":"HIV drug resistance, global antiretroviral therapy, pre-emptive screening and treatment of Cryptococcal disease"},{"lastName":"Shafer","clinicalFocus":[{"focus":"Infectious Disease"}],"appointments":[{"appointment":"Professor (Research),Medicine - Infectious Diseases"},{"appointment":"Professor (Research) (By courtesy),Pathology"}],"primaryAppointment":"Professor (Research),Medicine - Infectious Diseases","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4054&type=small&showNoImage","displayName":"Robert W. Shafer","firstName":"Robert","href":"http://med.stanford.edu/profiles/cancer/researcher/Robert_Shafer","researchInterest":"My group\u2019s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development.  Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance."},{"lastName":"Kahn","clinicalFocus":[],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - General Medical Disciplines"}],"primaryAppointment":"Professor - Med Center Line,Medicine - General Medical Disciplines","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=32885&type=small&showNoImage","displayName":"James Kahn","firstName":"James","href":"http://med.stanford.edu/profiles/cancer/researcher/James_Kahn","researchInterest":"My initial research activities involved antiretroviral and novel therapeutic treatments of HIV infection, understanding elements of HIV pathogenesis associated with acute HIV infection and post exposure prevention.  My most recent scholarly activities concentrate on working as a team to capitalize on the data stored in electronic medical records, HIV disease modeling and using electronic medical records for outcome research and developing a mentorship program for early career scientists."},{"lastName":"Rosenberg","clinicalFocus":[{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Lymphoma "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor Emeritus,Medicine - Oncology"},{"appointment":"Emeritus Faculty, Acad Council,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor Emeritus,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4127&type=small&showNoImage","displayName":"Saul A Rosenberg","firstName":"Saul","href":"http://med.stanford.edu/profiles/cancer/researcher/Saul_Rosenberg","researchInterest":"Clinical Interests: Hodgkin's disease and non-Hodgkin's lymphomas Research Interests: clinical trials, clinical-pathological-biological correlations"},{"lastName":"Wapnir","clinicalFocus":[{"focus":"Breast Cancer"},{"focus":"Breast Cancer - Surgery"},{"focus":"Breast Surgery"},{"focus":"General Surgery"},{"focus":"Nipple-sparing mastectomy, breast conserving surgery, sentinel node biopsy"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4337&type=small&showNoImage","displayName":"Irene Wapnir","firstName":"Irene","href":"http://med.stanford.edu/profiles/cancer/researcher/Irene_Wapnir","researchInterest":"Clinical treatment trials in Breast Cancer, especially local recurrence of breast cancer. Dr. Wapnir is institutional Principal Investigator for National Surgical Adjuvant Breast and Bowel Project (NSABP). Laboratory research includes exploring the activity of breast iodide transporter in breast cancer. These endeavors have lead to translational research protocols."},{"lastName":"Farquhar","clinicalFocus":[{"focus":"Cardiology (Heart), Preventive"},{"focus":"Cardiovascular Medicine"},{"focus":"Chronic Disease Prevention"},{"focus":"Global cancer prevention"}],"appointments":[{"appointment":"Professor Emeritus,Medicine - Stanford Prevention Research Center"},{"appointment":"Emeritus Faculty, Acad Council,Medicine - Stanford Prevention Research Center"}],"primaryAppointment":"Professor Emeritus,Medicine - Stanford Prevention Research Center","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=5956&type=small&showNoImage","displayName":"John W. Farquhar, M.D.","firstName":"John","href":"http://med.stanford.edu/profiles/cancer/researcher/John_Farquhar","researchInterest":"Disease prevention, epidemiology of cardiovascular diseases, community-based education for disease prevention, international health."}]}